Clinical trial
Randomized Comparison of the Immunogenicity of Recombinant and Egg-based Influenza Vaccines Among Healthcare Personnel in Israel
NCT04523324 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Comparison of the Immunogenicity of Recombinant and Egg-based Influenza Vaccines Among Healthcare Personnel in Israel
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2019
- Completion date
- August 30, 2022
- Enrollment
- 577 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
influenza